Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Uchida

Showing results (271-280 of 461) with videos related to

Pageof 47
Sort By:
Schizophrenia Research|February 5, 2014
Tardive dyskinesia in relation to estimated dopamine D2 receptor occupancy in patients with schizophrenia: analysis of the CATIE dataKazunari Yoshida, Robert R Bies, Takefumi Suzuki, et al.
Molecular Imaging and Biology|June 14, 2022
Striatal Dopaminergic Depletion Pattern Reflects Pathological Brain Perfusion Changes in Lewy Body DiseasesYu Iwabuchi, Tohru Shiga, Masashi Kameyama, et al.
Journal of Clinical Psychopharmacology|January 18, 2006
Reducing the dose of antipsychotic agents ameliorates visual hypersensitivity attack: an ideal treatment option in terms of the adverse effectHiroyuki Uchida, Takefumi Suzuki, Ryoko Yamazawa, et al.
Physical Chemistry Chemical Physics : PCCP|May 30, 2013
Effect of the state of distribution of supported Pt nanoparticles on effective Pt utilization in polymer electrolyte fuel cellsMakoto Uchida, Young-Chul Park, Katsuyoshi Kakinuma, et al.
Journal of Clinical Psychopharmacology|September 17, 2008
A randomized, open-label comparison of 2 switching strategies to aripiprazole treatment in patients with schizophrenia: add-on, wait, and tapering of previous antipsychotics versus add-on and simultaneous taperingHiroyoshi Takeuchi, Takefumi Suzuki, Hiroyuki Uchida, et al.
Schizophrenia Research|March 5, 2022
AMPA receptors in schizophrenia: A systematic review of postmortem studies on receptor subunit expression and bindingKengo Yonezawa, Hideaki Tani, Shinichiro Nakajima, et al.
Schizophrenia Research|January 26, 2016
Resilience in schizophrenia: A comparative study between a remote island and an urban area in JapanKazunari Yoshida, Takefumi Suzuki, Yasushi Imasaka, et al.
Schizophrenia Research|September 14, 2013
Estimated dopamine D2 receptor occupancy from plasma concentrations of atypical antipsychotics and subjective experience/drug attitude in schizophrenia: an analysis of the CATIE dataHiroyoshi Takeuchi, Takefumi Suzuki, Robert R Bies, et al.
Therapeutic Drug Monitoring|March 2, 2012
Predicting plasma concentration of risperidone associated with dosage change: a population pharmacokinetic studyHiroyuki Uchida, David C Mamo, Bruce G Pollock, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|July 4, 2013
C-terminus of the Sgf73 subunit of SAGA and SLIK is important for retention in the larger complex and for heterochromatin boundary functionKazuma Kamata, Akira Hatanaka, Gayatri Goswami, et al.
Pageof 47

Showing results (271-280 of 461) with videos related to

Sort By:
Pageof 47
Schizophrenia Research|February 5, 2014
Tardive dyskinesia in relation to estimated dopamine D2 receptor occupancy in patients with schizophrenia: analysis of the CATIE dataKazunari Yoshida, Robert R Bies, Takefumi Suzuki, et al.
Molecular Imaging and Biology|June 14, 2022
Striatal Dopaminergic Depletion Pattern Reflects Pathological Brain Perfusion Changes in Lewy Body DiseasesYu Iwabuchi, Tohru Shiga, Masashi Kameyama, et al.
Journal of Clinical Psychopharmacology|January 18, 2006
Reducing the dose of antipsychotic agents ameliorates visual hypersensitivity attack: an ideal treatment option in terms of the adverse effectHiroyuki Uchida, Takefumi Suzuki, Ryoko Yamazawa, et al.
Physical Chemistry Chemical Physics : PCCP|May 30, 2013
Effect of the state of distribution of supported Pt nanoparticles on effective Pt utilization in polymer electrolyte fuel cellsMakoto Uchida, Young-Chul Park, Katsuyoshi Kakinuma, et al.
Journal of Clinical Psychopharmacology|September 17, 2008
A randomized, open-label comparison of 2 switching strategies to aripiprazole treatment in patients with schizophrenia: add-on, wait, and tapering of previous antipsychotics versus add-on and simultaneous taperingHiroyoshi Takeuchi, Takefumi Suzuki, Hiroyuki Uchida, et al.
Schizophrenia Research|March 5, 2022
AMPA receptors in schizophrenia: A systematic review of postmortem studies on receptor subunit expression and bindingKengo Yonezawa, Hideaki Tani, Shinichiro Nakajima, et al.
Schizophrenia Research|January 26, 2016
Resilience in schizophrenia: A comparative study between a remote island and an urban area in JapanKazunari Yoshida, Takefumi Suzuki, Yasushi Imasaka, et al.
Schizophrenia Research|September 14, 2013
Estimated dopamine D2 receptor occupancy from plasma concentrations of atypical antipsychotics and subjective experience/drug attitude in schizophrenia: an analysis of the CATIE dataHiroyoshi Takeuchi, Takefumi Suzuki, Robert R Bies, et al.
Therapeutic Drug Monitoring|March 2, 2012
Predicting plasma concentration of risperidone associated with dosage change: a population pharmacokinetic studyHiroyuki Uchida, David C Mamo, Bruce G Pollock, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|July 4, 2013
C-terminus of the Sgf73 subunit of SAGA and SLIK is important for retention in the larger complex and for heterochromatin boundary functionKazuma Kamata, Akira Hatanaka, Gayatri Goswami, et al.
Pageof 47